Jessica L. Pressley

FDA investigator

Appears on 24 documents from 2014 to 2021, mostly at sites in Florida. Most often cites control of microbiological contamination (21 CFR 211.113).

24
Documents on file
8.2
Observations per 483
2014
First seen
2021
Most recent

What they cite most

From 198 observations

Activity by year

2014: 1, 2015: 1, 2016: 5, 2017: 3, 2018: 2, 2019: 6, 2020: 5, 2021: 1

Where

Florida 17 · South Carolina 3 · India 1 · Japan 1 · Mexico 1 · United Kingdom 1

Is Jessica L. Pressley coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

24 documents, newest first
FirmOpen
483 BPI Labs LLCApr 30, 2021 · Largo, Florida
483 B. Braun US Pharmaceutical Manufacturing LLCOct 30, 2020 · Daytona Beach, Florida
483 Allay Pharmaceuticals, LLCMay 15, 2020 · Miami, Florida
483 The Medicine Shoppe PharmacyMar 16, 2020 · Port Charlotte, Florida
483 Maitland Labs of Central FloridaFeb 28, 2020 · Orlando, Florida
483 Form 483 · FEI 3011103365Feb 7, 2020 · Brooksville, Florida
483 Nephron Pharmaceuticals Corporation dbaNov 15, 2019 · West Columbia, South Carolina

About this profile

What does Jessica L. Pressley inspect?

Jessica L. Pressley appears on 24 documents on file covering 23 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by FDCA 501(a)(2)(A) and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jessica L. Pressley is dated Apr 30, 2021.